B of A Securities Downgrades Hill-Rom Holdings to Neutral, Announces $130 Price Target
B of A Securities analyst Bob Hopkins downgrades Hill-Rom Holdings (NYSE:HRC) from Buy to Neutral and announces $130 price target.
Keybanc Maintains Overweight on Hill-Rom Holdings, Raises Price Target to $145
Keybanc analyst Matthew Mishan maintains Hill-Rom Holdings (NYSE:HRC) with a Overweight and raises the price target from $131 to $145.
Hill-Rom Holdings: Q3 Earnings Insights
Shares of Hill-Rom Holdings (NYSE:HRC) were unchanged after the company reported Q3 results.
Quarterly Results
Earnings per share decreased 29.23% year over year to $1.38, which beat the estimate of $1.34.
Earnings Scheduled For July 30, 2021
Companies Reporting Before The Bell
• Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its second quarter.
Stocks That Hit 52-Week Highs On Wednesday
During Wednesday's morning trading, 125 companies set new 52-week highs.
Hillrom Comments On Delaware Court Of Chancery Ruling
Hillrom (NYSE:HRC) today announced that the Delaware Court of Chancery ordered Hillrom to proceed with its proposed acquisition of Bardy Diagnostics, Inc. (BardyDx), denying Hillrom's claim of a Material Adverse
Raymond James Maintains Outperform on Hill-Rom Holdings, Raises Price Target to $122
Raymond James analyst Lawrence Keusch maintains Hill-Rom Holdings (NYSE:HRC) with a Outperform and raises the price target from $120 to $122.
Earnings Scheduled For April 30, 2021
Companies Reporting Before The Bell
• O2Micro Intl (NASDAQ:OIIM) is estimated to report quarterly earnings at $0.09 per share on revenue of $23.30 million.